The objectives of the European Society of Veterinary Pathology are to promote the scientific work of veterinary surgeons and physicians active in the areas of functional and morphologic pathology of animals, as well as that of other interested natural scientists, by means of organising scientific post-graduate training, conferences and meetings.
Learn more about the history, mission and vision of the ESVP.
On the Inside:
AGRICULTURE, FISHERIES AND CONSERVATION DEPARTMENT
Head of Diagnostic Services (Veterinary Pathology) (Non-civil Service Vacancy)
Location: Hong Kong
Salary: HKD$126,220/month
Closing Date for Application: Until the position is filled
At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us.
September 07th – September 10th, 2022
The meeting website is now online! Please, follow the link below to keep you updated on the scientific program, the venue and registration!
Current perspectives concerning soft tissue tumors
12th- 14th May 2022 / Virtual or hybrid (Maisons-Alfort, EnvA)
Guest speakers :Rob Foster (University of Guelph, Canada), Melanie Dobromylskyj (Finn Pathologists, Harleston, UK)
Veterinary Pathologist at BASF SE
Our Bioscience Research Division works on innovative and sustainable solutions for our customers in sectors, such as the agricultural sector or food industry. Our goal is to improve the quality of life and protect the environment through bioscience. Our creative and diverse team embodies mutual respect and develops market-driven innovations, which make our customers successful.
Tthe University of Hannover, the Deutsche Forschungsgemeinschaft (DFG) German Research Foundation and the Research Training Group (RTG) 2485 are pleased to invite you to the first Virus detection, pathogenesis and intervention (VIPER) symposium. This is a great opportunity to attend an up-to-date discussion on the hot topics of emerging viral diseases and viruses with pandemic potential.
We are delighted to invite you to attend the Continuing Education Symposium 5 on the Female Reproductive System, which will be held online on the afternoons of 8th, 9th, 10th, 15th, 16th and 17th March, 2022. This symposium will give you the opportunity to learn about species differences in the female reproductive tract as well as sexual immaturity, reproductive senescence, neoplasia and related International Harmonization of Nomenclature and Diagnostic Criteria (INHAND) nomenclature. We will also cover regulatory Developmental and Reproductive Toxicology (DART) study packages and endocrine disruption. You will have direct access to international key speakers and exposure to pharmaceutical, agrochemical and biotechnology case studies.
On the Inside:
Seminar offered by the Hannover Graduate School for Veterinary Pathobiology, Neuroinfectiology, and Translational Medicine, and the Department of Pathology at the University of Veterinary Medicine in Hannover, Germany, and the European Society of Toxicologic Pathology on March 10 and 11, 2022
The webinar committee likes to invite you all to attend the October 29 webinar on Translational Animal Models of Disease.
Saturday the 11th of September at 10 pm AEST (9 am BRT, 1 pm BST, 2 pm CET) the GIVCS (Global Initiative for Veterinary Cancer Surveillance) is presenting the UQ global engagement seed funding project on veterinary cancer surveillance – a collaboration between UQ (Australia), UNESP (Brazil), Sao Paulo State University (Brazil), Technical University of Munich (Germany), The University of Zurich (Switzerland), Pontifical Catholic University (Chile), Nong Lam University (Vietnam) and Universitas Brawyjaya (Indonesia) .
The BSTP's 36th Annual Scientific Meeting will cover the topic of pathology of mice with human immune systems (HIS mice).
Immunodeficient mice reconstituted with a human immune system are increasingly used for modelling the human immune compartment in numerous preclinical applications, such as adoptive cell therapy and immuno-oncology studies. With the advent of new Advanced Therapy Medicinal Products, humanised mice are likely to become more and more a key component of efficacy and safety assessment in preclinical programmes, including GLP studies. However, limited information is available concerning the morphological aspects of human cell engraftment and the spectrum of spontaneous and experimentally-induced histopathological lesions occurring in these mice.
